Normative Values, Testability, and Validity for a New Preferential Looking Stereoacuity Test
- PMID: 33555995
- PMCID: PMC7971100
- DOI: 10.1080/2576117X.2021.1874776
Normative Values, Testability, and Validity for a New Preferential Looking Stereoacuity Test
Abstract
Introduction: Age norms and testability for 3-5 year old children have been reported for the PASS III stereotest using a pointing response. We aimed to expand the normative data to children as young as 6 months, assess testability, and evaluate validity use of the PASS III as a preferential-looking test for younger children and children with special needs. Methods: 68 control children, 362 children with eye conditions, and 167 children with special needs were tested with the PASS III. Percent testable was calculated for children with and without special needs, normal tolerance limits were determined, and test validity was assessed. Results: In controls, mean PASS III stereoacuity improved from 371 arcsec at 12 months to 174 arcsec at 24 months, and 87 arcsec at 36 months. Testability in the 12, 24, and 36 months age groups were 81%, 87%, and 97% respectively and 92% for special needs children. Comparison to previously published norms and testing in a known nil stereoacuity cohort supported PASS III test validity. Compared to gold standard stereoacuity tests, accuracy of the PASS was 89%. Conclusion: Overall, preferential-looking tests using the PASS III provide a sensitive and specific measure of stereoacuity with high testability for young children and children with special needs.
Keywords: PASS III; Stereoacuity; child; infant; special needs.
Conflict of interest statement
Declaration of Conflict Statement
None of the authors has a conflict of interest with any of the material presented in this manuscript.
Figures



References
-
- Drover JR, Cornick SL, Hallett D, et al. Normative pediatric data for three tests of functional vision. Can J Ophthalmol 2017;52:198–202. - PubMed
-
- Mayer DL, Beiser AS, Warner AF, et al. Monocular acuity norms for the Teller acuity cards between ages one month and four years. Invest Ophthalmol Vis Sci 1995;36:671–85. - PubMed
-
- Salomao SR, Ventura DF. Large sample population age norms for visual acuities obtained with Vistech-Teller Acuity Cards. Invest Ophthalmol Vis Sci 1995;36:657–70. - PubMed
-
- Holmes JM, Beck RW, Repka MX, et al. The amblyopia treatment study visual acuity testing protocol. Arch Ophthalmol 2001;119:1345–53. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources